-
December 17, 2019PREVIEW
Treatment with nintedanib (Ofev—Boehringer Ingelheim) slowed the rate of decline in pulmonary function in adults with interstitial lung disease (ILD) associated with systemic sclerosis, according...
-
August 27, 2019PREVIEW
Use of aclidinium bromide (Tudorza Pressair—Circassia) in patients with chronic obstructive pulmonary disease (COPD) and established cardiovascular (CV) disease or CV risk factors was noninferior...
-
June 10, 2019PREVIEW
Omadacycline (Nuzyra—Paratek) was shown to be noninferior to moxifloxacin for management of hospitalized adults with community-acquired bacterial pneumonia (CABP) for early clinical response,...
-
March 26, 2019PREVIEW
Data from a large Danish population–based study showed that treatment with beta-blockers, regardless of their selectivity on bronchial tone, was associated with a reduced risk of chronic...
-
March 26, 2019PREVIEW
One-year abstinence rates were significantly higher in people who smoked who were randomized to e-cigarettes compared with those given nicotine-replacement therapies (NRTs), according to results...
Pages
